Echinacea in hepatopathy: A review of its phytochemistry, pharmacology, and safety

被引：26

作者：

Xu, Wenqian ^{[1
,2
]}

Zhu, Hongkang ^{[1
,2
]}

Hu, Bin ^{[1
,2
]}

Cheng, Yuliang ^{[1
,2
]}

Guo, Yahui ^{[1
,2
]}

Yao, Weirong ^{[3
]}

Qian, He ^{[1
,2
]}

机构：

[1] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, 1800 Lihu Ave, Wuxi 214122, Jiangsu, Peoples R China

[2] Jiangnan Univ, Int Joint Lab Food Safety, Wuxi 214122, Jiangsu, Peoples R China

[3] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China

来源：

PHYTOMEDICINE | 2021年 / 87卷

关键词：

Echinacea; Hepatopathy; Phytochemistry; Pharmacology; Safety; PURPUREA L. MOENCH; IN-VITRO; HEPATITIS-C; CYTOCHROME-P450; 3A4; PHENOLIC-COMPOUNDS; OXIDATIVE STRESS; HERBAL EXTRACTS; LIVER-DISEASE; ACID; HEPATOTOXICITY;

D O I：

10.1016/j.phymed.2021.153572

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

Background: Echinacea, one of the most popular herbs with double function of immunity and anti-inflammatory activity, has now attracted much interest for a possible alternative for the treatment of hepatopathy. This review is aimed at providing a comprehensive overview of Echinacea regarding its chemical composition, pharmacological action against various hepatopathy, and safety. Methods: A comprehensive search of published articles was conducted to focus on original publications related to Echinacea and hepatopathy till the end of 2020 using various literature databases, including China National Knowledge Infrastructure, PubMed, and Web of Science database. Results: Echinacea exhibited excellent activities in resisting a variety of hepatopathy induced by different causes in preclinical experiments and clinical trials by regulating cell proliferation and apoptosis, antioxidant defense mechanism, voltage-gated sodium channels, lipid metabolism, circadian rhythm, p38 MAPK signaling pathway, JNK signaling pathway, Nrf2/HO-1 signaling pathway, PI3K/AKT signaling pathway, and Akt/GSK3 beta signaling pathways. The high efficacy of Echinacea is related to its immunomodulatory and anti-inflammatory activities. The main ingredients of Echinacea include caffeic acid derivatives, alkylamides, and polysaccharides, which have been well established in preclinical studies of liver diseases. Studies on acute and subacute toxicity show that Echinacea preparations are well-tolerated herbal medicines. Conclusion: Echinacea may offer a novel potential strategy for clinical prevention and treatment of liver diseases and related diseases. Extensive studies are necessary to identify the underlying mechanisms and establish future therapeutic potentials of this herb. Well-designed clinical trials are still warranted to confirm the safety and effectiveness of Echinacea for hepatopathy.

引用

页数：12

共 93 条

[91] Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome p450 3A4, 2D6, and 2C9 [J].